在放射治疗前用伦瓦提尼布进行诱导化疗治疗的局部不可切除的胸膜癌
Shodai Fujimoto1, Naoko Katsurada1, Rie Sasaki2
1Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan.
Internal medicine (Tokyo, Japan)
|November 10, 2024
概括
伦瓦提尼布是一种向疗法,在放射治疗之前显示出作为诱导化疗对不可切除的胸膜癌的诱导化疗的希望. 这种方法可能为这种罕见的癌症提供一种新的治疗选择.
科学领域:
- 在瘤学瘤学.
- 医学研究 医学研究
背景情况:
- 胸膜癌是一种罕见的癌症,治疗策略有限.
- 伦瓦提尼布是一种针对性治疗,已被批准用于晚期胸腺癌.
- 在放射治疗之前的诱导化疗用于局部化,不可切除的胸膜癌并未得到很好的证实.
研究的目的:
- 评估伦瓦提尼布作为诱导化疗用于局部化,不可切除的胸膜癌的疗效.
- 报告一例成功使用伦瓦提尼布治疗,随后进行放射治疗的病例.
主要方法:
- 一个单一的病例报告是一位85岁的日本妇女,患有局部不可切除的胸腺癌.
- 在放射治疗之前,作为诱导化疗的伦瓦提尼布的使用.
主要成果:
- 患者接受了伦瓦提尼布诱导化疗,随后进行放射治疗.
- 这些发现表明,伦瓦提尼布在这种临床环境中具有潜在的效用.
结论:
- 伦瓦提尼布可能是局部,不可切除的胸膜癌症的诱导化疗的可行选择.
- 需要进一步的研究,以在更大的研究中证实这些发现.
更多相关视频
03:55Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
482
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.4K
相关概念视频
01:27Tumor Immunotherapy
480
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
480
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K